Bruno Coudert

2PUBLICATIONS
11CO-AUTHORS
Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 15, 2021
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

Hossein Borghaei, Scott Gettinger, Everett E Vokes

|Aug 30, 2018
Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients.

Corentin Richard, Jean-David Fumet, Sandy Chevrier

Pageof 1